Crossmark

Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance

Crossref DOI link: https://doi.org/10.1039/C8NR02700E

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Xiao, Yating

Liu, Jing

Guo, Mengyu

Zhou, Huige

Jin, Jun

Liu, Jiaming

Liu, Ying

Zhang, Zhanjun

Chen, Chunying https://orcid.org/0000-0002-6027-0315
Funding

Funding for this research was provided by:

Ministry of Science and Technology of the People's Republic of China (2016YFA0201600)

National Natural Science Foundation of China (11621505)

National Natural Science Foundation of China (11425520)
License Information

Accepted Manuscript valid from 2019-06-12
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Chunying Chen (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 3 April 2018; Accepted 12 June 2018; Accepted Manuscript published 12 June 2018; Advance Article published 26 June 2018; Version of Record published 9 July 2018